Gyre Therapeutics (GYRE) FCF Margin Growth (3y) (2013 - 2026)
Gyre Therapeutics (GYRE) FCF Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
10,029.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
723.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Gyre Therapeutics |
554.75 Mn |
540.62 Mn |
8.38 Mn |
-2,138.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-2,138.00 |
| Dec 31, 2025 |
-5,712.00 |
| Mar 31, 2025 |
151,649.00 |
| Dec 31, 2024 |
71,476.00 |
| Sep 30, 2024 |
96,499.00 |
| Jun 30, 2024 |
175,010.00 |
| Mar 31, 2024 |
167,002.00 |
| Dec 31, 2023 |
109,264.00 |
| Sep 30, 2023 |
149,600.00 |
| Jun 30, 2023 |
92,088.00 |
| Mar 31, 2023 |
6,417.00 |
| Mar 31, 2021 |
8.68 Mn |
| Dec 31, 2020 |
90,394.00 |
| Sep 30, 2020 |
7,150.00 |
| Jun 30, 2020 |
305,189.00 |
| Mar 31, 2020 |
155,550.00 |
| Mar 31, 2018 |
-8.80 Mn |
| Dec 31, 2017 |
-168,637.00 |
| Sep 30, 2017 |
-510,192.00 |
| Jun 30, 2017 |
-96,476.00 |
